Truist Financial Corp Regeneron Pharmaceuticals, Inc. Transaction History

Truist Financial Corp

  • $62.9 Billion
  • Q3 2024

A detailed history of Truist Financial Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 37,111 shares of REGN stock, worth $27.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
37,111
Previous 40,221 7.73%
Holding current value
$27.5 Million
Previous $42.3 Million 7.71%
% of portfolio
0.06%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$1024.09 - $1201.76 $3.18 Million - $3.74 Million
-3,110 Reduced 7.73%
37,111 $39 Million
Q2 2024

Aug 20, 2024
SELL
$883.2 - $1071.19 $1.44 Million - $1.75 Million
-1,630 Reduced 3.89%
40,221 $42.3 Million
Q1 2024

May 10, 2024
SELL
$902.69 - $993.35 $2.28 Million - $2.51 Million
-2,530 Reduced 5.7%
41,851 $40.3 Million
Q4 2023

Feb 02, 2024
SELL
$775.18 - $881.7 $6.25 Million - $7.11 Million
-8,062 Reduced 15.37%
44,381 $39 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $19.7 Million - $24.1 Million
-28,515 Reduced 35.22%
52,443 $43.2 Million
Q2 2023

Aug 01, 2023
SELL
$700.03 - $830.35 $9.69 Million - $11.5 Million
-13,849 Reduced 14.61%
80,958 $58.2 Million
Q1 2023

May 05, 2023
SELL
$680.49 - $826.97 $11 Million - $13.3 Million
-16,129 Reduced 14.54%
94,807 $77.9 Million
Q4 2022

Feb 17, 2023
SELL
$705.89 - $766.39 $4.37 Million - $4.74 Million
-6,189 Reduced 5.28%
110,936 $80 Million
Q3 2022

Oct 26, 2022
SELL
$573.97 - $724.32 $4.91 Million - $6.2 Million
-8,560 Reduced 6.81%
117,125 $80.7 Million
Q2 2022

Jul 22, 2022
SELL
$548.35 - $738.84 $5.61 Million - $7.56 Million
-10,239 Reduced 7.53%
125,685 $74.3 Million
Q1 2022

Apr 22, 2022
SELL
$595.12 - $698.43 $3.93 Million - $4.62 Million
-6,610 Reduced 4.64%
135,924 $94.9 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $101,630 - $125,471
-187 Reduced 0.13%
142,534 $90 Million
Q3 2021

Nov 05, 2021
SELL
$574.03 - $680.96 $4.06 Million - $4.82 Million
-7,077 Reduced 4.72%
142,721 $86.4 Million
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $9.01 Million - $10.6 Million
19,063 Added 14.58%
149,798 $83.7 Million
Q1 2021

May 17, 2021
BUY
$446.73 - $548.2 $25.2 Million - $30.9 Million
56,371 Added 75.8%
130,735 $61.9 Million
Q4 2020

Feb 18, 2021
BUY
$478.3 - $607.98 $3.71 Million - $4.72 Million
7,761 Added 11.65%
74,364 $35.9 Million
Q3 2020

Nov 13, 2020
SELL
$544.75 - $658.21 $3.16 Million - $3.82 Million
-5,810 Reduced 8.02%
66,603 $37.3 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $3.3 Million - $4.3 Million
6,681 Added 10.16%
72,413 $45.2 Million
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $9.01 Million - $13.2 Million
26,797 Added 68.82%
65,732 $32.1 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $4.78 Million - $6.56 Million
17,419 Added 80.96%
38,935 $14.6 Million
Q3 2019

Oct 31, 2019
BUY
$273.46 - $318.39 $424,956 - $494,778
1,554 Added 7.78%
21,516 $5.97 Million
Q2 2019

Jul 24, 2019
BUY
$299.6 - $414.82 $35,952 - $49,778
120 Added 0.6%
19,962 $6.25 Million
Q1 2019

Apr 23, 2019
BUY
$372.08 - $439.57 $459,146 - $542,429
1,234 Added 6.63%
19,842 $8.15 Million
Q4 2018

Jan 22, 2019
BUY
$335.82 - $403.04 $655,856 - $787,137
1,953 Added 11.73%
18,608 $6.95 Million
Q3 2018

Oct 17, 2018
BUY
$351.14 - $408.51 $584,648 - $680,169
1,665 Added 11.11%
16,655 $6.73 Million
Q2 2018

Jul 26, 2018
BUY
$284.6 - $344.99 $759,312 - $920,433
2,668 Added 21.65%
14,990 $5.17 Million
Q1 2018

Apr 20, 2018
BUY
$315.82 - $393.78 $475,940 - $593,426
1,507 Added 13.93%
12,322 $4.24 Million
Q4 2017

Jan 29, 2018
BUY
$358.63 - $469.95 $246,020 - $322,385
686 Added 6.77%
10,815 $4.07 Million
Q3 2017

Oct 23, 2017
BUY
$431.38 - $504.0 $4.37 Million - $5.11 Million
10,129
10,129 $4.53 Million

Others Institutions Holding REGN

# of Institutions
1,535
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email